"Partners In Nephrology & Endocrinology (PINE) is the western Pennsylvania region’s most recognized and experienced nephrology and endocrinology group. Our practice has been at the forefront of the treatment and management of kidney and endocrine diseases for more than 35 years. Today, we continue to use the most advanced diagnostic and treatment tools available to treat and support those living with illnesses such as Kidney Disease, Hypertension, Diabetes and Thyroid Disorders. Our practice currently includes over 30 providers, who are working out of multiple convenient locations in Pennsylvania's Allegheny, Washington, Butler, Westmoreland, and Lawrence counties."

During the past decade, Partners in Nephrology & Endocrinology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Partners in Nephrology & Endocrinology" #1 collaborator was "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Partners in Nephrology & Endocrinology" are "Diabetes Mellitus, Type 2" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Chronic Kidney Disease" (1 trials), "Renal Insufficiency" (1 trials) and "Type 1 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Partners in Nephrology & Endocrinology" in a lesser frequency.

Most popular intervention types in "Partners in Nephrology & Endocrinology" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (2 trials), "Insulin Glargine" (2 trials), "Insulin Lispro" (2 trials), "LY900014" (2 trials) and "vildagliptin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Partners in Nephrology & Endocrinology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Partners in Nephrology & Endocrinology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Partners in Nephrology & Endocrinology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Partners in Nephrology & Endocrinology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".